OTCMKTS:CBBT Cerebain Biotech (CBBT) Stock Price, News & Analysis $0.0009 0.00 (0.00%) As of 09/2/2021 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Cerebain Biotech Stock (OTCMKTS:CBBT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cerebain Biotech alerts:Sign Up Key Stats Today's Range$0.0008▼$0.001050-Day Range N/A52-Week Range$0.00▼$0.47Volume2.04 million shsAverage Volume11.21 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Cerebain Biotech Corp. is a biomedical company, which engages in the creation and clinical development of a minimally invasive implantable device. It focuses on the discovery of products for the treatment of Alzheimer's disease utilizing Omentum. The company was founded on December 18, 2007 and is headquartered in Costa Mesa, CA. Read More Receive CBBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cerebain Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address CBBT Stock News HeadlinesCBBT expansion back in motion after crews discover centuries-old anchor, halting project for monthsAugust 29, 2024 | msn.comImClone Founder Waksal Forming New Biotech VentureOctober 28, 2023 | thestreet.comTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.July 6 at 2:00 AM | Porter & Company (Ad)Duopharma Biotech Bhd (DUOP)September 19, 2023 | investing.comFormer Google AI expert raises $100mn for biotech start-upSeptember 10, 2023 | ft.comPharmAla Biotech to supply University of California Clinical Trial with LaNeo™ MDMAOctober 6, 2022 | finance.yahoo.comJapan Biotech Startups Directory 2022September 15, 2022 | finance.yahoo.comCerebain Biotech Closes Share Exchange Agreement With PKG, Inc.September 20, 2021 | finance.yahoo.comSee More Headlines CBBT Stock Analysis - Frequently Asked Questions How have CBBT shares performed this year? Cerebain Biotech's stock was trading at $0.0009 at the start of the year. Since then, CBBT shares have increased by 0.0% and is now trading at $0.0009. How do I buy shares of Cerebain Biotech? Shares of CBBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cerebain Biotech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cerebain Biotech investors own include Bionano Genomics (BNGO), Aurora Cannabis (ACB), HUMBL (HMBL), Carnival (CCL), Canopy Growth (CGC), Enzolytics (ENZC) and SNDL (SNDL). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryWholesale Current SymbolOTCMKTS:CBBT CIKN/A Webwww.cerebain.com Phone(714) 371-4109FaxN/AEmployees2Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report This page (OTCMKTS:CBBT) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerebain Biotech Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cerebain Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
